Chirurgia delle recidive dei carcinomi differenziati della tiroide

Robbins J, Merino MJ, Boice JD Jr, Ron E, Ain KB, Alexander HR, Norton JA, Reynolds J. Thyroid cancer: a lethal endocrine neoplasm. Ann Intern Med 115, 133, 1991.

Taylor H, Heyer S, Vini L, Pratt B, Cook G, Harmer C. Diagnostic 131I whole body scanning after thyroidectomy and ablation for differenziated thyroid cancer. Eur J. Endocrinol 150: 649, 2004.

Salvatori M, Raffaelli M, Castaldi P, Treglia G, Rufini V, Perotti G, Lombardi CP, Rubello D, Ardito G, Bellantone R. Evaluation of the surgical completeness after total thyroidectomyfor differentiated thyroid carcinoma Eur J Surg Oncol 33: 648, 2007.

Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W, European Thyroid Cancer Taskforce. European consensus for the management of patients withdifferentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154: 787, 2006.

Mazzaferri EL, McIver B, Sherman SI. Management guidelines for patient with thyroid nodules and differentiated thyroid cancer. Thyroid 16, 109, 2006.

Pacini F, Molinaro E, Castagna MG, Agate L, Elisei R, Ceccarelli C, Lippi F, Taddei D, Grasso L, Pinchera A. Recombinant human thyrotropin-stimulate serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 88: 3668, 2003.

Schlumberger M, Berg G, Cohen O, Duntas L, Jamar F, Jarzab B, Limbert E., Lind P, Pacini F, Reiners C, Franco, F.S., Toft A, Wiersinga WM. Follow-up of lowrisk patients with differentiated thyroid carcinoma: a European perspective. Eur J Endocrinol 150: 105, 2004.

Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, Haugen BR, Sherman SI, Cooper DS, Braunstein GD, Lee S, Davies TF, Arafah, BM, Ladenson PW, Pinchera A. A consensus report of the role of serum thyroglobulin as a monitoring method of low-risk patients with papillary thyroid carcinoma. J. Clin Endocrinol Metab 2003: 88, 1433, 2003.

Frasoldati A, Pesenti ML, Gallo M, Caroggio A, Salvo D, Valcavi R. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 97: 90, 2003.

Frilling A, Georges R, Tecklenborg K. Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma. Surgery 128, 1067, 2000.

Finkelstein SE, Grigsby PW, Siegel BA, Dehdashti F, Moley JF, Hall BL. Combined [18F]fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer. Ann Surg Oncol 15: 286, 2008

DeGroot LJ, Kaplan EL. Second operation for “completation” of thyroidectomy in treatment of differenziated thyroid cancer. Surgery 110: 939, 1991.

Grant CS, Hay ID, Goug IR, Bergstralh EJ, Goellner JR, McConahey WM. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery 104: 954, 1988.

Stojadinovic A, Shoup M, Nissan A, Ghossein RA, Shah JP, Brennan MF, Shaha AR. Recurrent differentiated thyroid carcinoma: biological implications of age, method of detection, and site and extent of recurrence. Ann Surg Oncol 9: 789, 2002.

Marchesi M, Biffoni M, Biancari F, Berni A, Campana FP. Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma. Eur J Surg Suppl (588): 46, 2003.

Sugitani I, Fujimoto Y, Yamamoto N. Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control. Surgery 143: 35, 2008.

Scheumann GF, Gimm O, Wegener G, Hundeshagen H, Dralle H. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 18: 559; discussion 567, 1994.

Scheumann GF, Seeliger H, Musholt TJ, Gimm O, Wegener G, Dralle H, Hundeshagen, H, Pichlmayr R. Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. Eur J Surg 162: 677, 1996.